IDXX Q1 2024 Earnings — IDEXX Laboratories, Inc. Revenue & Financial Results | Market Cap Arena

IDXXIDEXX Laboratories, Inc.

$48B

Q1 2024 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$964M+7.1% YoY

Gross Profit

$593M61.5% margin

Operating Income

$299M31.0% margin

Net Income

$236M24.4% margin

EPS (Diluted)

$2.81

QoQ Revenue Growth

+6.9%

Cash Flow

Operating Cash Flow

$199M

Free Cash Flow

$168M

Stock-Based Comp.

$14M

Balance Sheet

Total Assets

$3.4B

Total Liabilities

$1.8B

Stockholders' Equity

$1.6B

Cash & Equivalents

$397M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$964M	$900M	+7.1%
Gross Profit	$593M	$543M	+9.2%
Operating Income	$299M	$280M	+6.6%
Net Income	$236M	$214M	+10.1%

Revenue Segments

Product

$543M56%

Service

$421M44%

Geographic Segments

UNITED STATES

$631M65%

EMEA

$200M21%

Asia Pacific

$76M8%

CANADA

$37M4%

Latin America

$20M2%